Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
about
The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single sourceModulation of RANTES expression by HCV core protein in liver derived cell linesFactors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic HepatitisHost Genetic Factors and Antiviral Immune Responses to Hepatitis C VirusRole of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infectionSynergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effectsInterference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injuryImmunology of hepatitis B virus and hepatitis C virus infectionPharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variantsA DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cellsCCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infectionAge-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2Liver cirrhosisChemokines in the immunopathogenesis of hepatitis C infectionCCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population.Clinical significance of the CCR5delta32 allele in hepatitis CPseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus).Association of genetic variations in GNB1 with response to peginterferon plus ribavirin therapy for chronic hepatitis C in a Chinese population in Taiwan.Constitutional telomerase mutations are genetic risk factors for cirrhosis.Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearanceHost genetic determinants of spontaneous hepatitis C clearance.Clinical use of CCR5 inhibitors in HIV and beyondCoinfection with HIV-1 and HCV--a one-two punch.Role of host genetic factors in the outcome of hepatitis C virus infection.Clinical implications of chemokines in acute and chronic hepatitis C virus infection.Role of genetic polymorphisms in hepatitis C virus chronic infection.The role of CCR5 in HCV infectionDiscovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection.A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject DrugsAssociation of Chemotactic Chemokine Ligand 5 Polymorphisms with the Risk of Developing Severe Enterovirus 71 Infection.HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?Host genetic variants in the pathogenesis of hepatitis C.Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional studyImpaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionThe chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realityChemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.CCR1 and CCR5 promote hepatic fibrosis in mice
P2860
Q27477986-79A23857-81FC-4041-8521-80F3D2AE8A46Q27480801-0DE389C8-BB97-4570-B7BA-909C2235C4FBQ27480999-98FFAA4F-060D-41B1-98A4-4CA7C9821504Q27487445-E088E8A9-939C-425D-AF8B-50DBBED417FFQ27490393-7461CED8-0FDD-4D49-B8BB-BA908EDA6018Q28235478-25003A4A-1900-4C9D-AF79-056B2C7FB53CQ28730116-945961E1-9079-49EC-B269-A766879542E7Q29618957-6E3D75CE-BF3A-4B0F-AE0A-CB073BA824ADQ33404251-5C8E811A-9212-4059-BBCD-AAA5C47A773FQ33648379-D35BCEA0-32E8-4DBE-AF1A-DB3748E71F8DQ33867870-D9540C2E-66F2-45F4-9251-E22EBD0BA882Q33904205-788D0510-6DFA-4BD8-B1C4-33B09FC55ADAQ33908877-248C7431-BDCE-4660-90DE-CCDEA636AF15Q34010340-A2B59D2F-D66F-4A24-B6C8-35BA807F504EQ34056271-D9D492B3-AE4C-48F2-B4D0-64F9580B9CB7Q34098888-842BC1FC-9DB3-44DF-B5AE-4497AA9A0E83Q34142349-7D00B687-425B-4EFF-9133-8835C9BED144Q34380801-16FC0BD5-F8D1-4ED8-93D0-1693C840F44CQ34484305-75B9EB1A-0984-4FB9-838A-1C3E1D493A6AQ34862975-17CFAC74-8076-491C-83EE-E43844E1D879Q34914406-76659C0E-2515-4051-A8A0-2A61E29D7757Q35011376-C69E5463-2F0D-4371-8594-54B12D2D3F2AQ35018145-4F373D73-B0AF-4CB0-8FAE-22B93BDF4988Q35137038-38097622-9EB9-455F-AAEB-97520C7E6C3CQ35259735-7AACC7ED-4E8D-4BBA-98A3-F4A06F94F959Q35561908-EB7DC949-E108-4C39-8FFA-188A2A9665EBQ35779058-551DFCD7-FB66-4441-A3B2-12FC94A8465FQ35960061-7E8E9392-2BA6-4ED8-8384-7762EB10BC6FQ36048467-FDAEE001-B153-4CFD-B7AA-F7A265C4A262Q36053084-C2313D33-9E18-4383-BFE3-70C997232828Q36131940-38BDA041-78B1-4F8C-9745-933335EF50B4Q36479368-0F492AB9-6506-46FD-B87A-AE3DF5B929D1Q36482742-4338E650-6B03-42A7-818D-97CCC8BDE1DFQ36503328-C7C07868-2392-4111-B128-B1851525668CQ36606736-5BC63727-4F14-4715-B9EB-88D4C2659E71Q36611680-8A92BDD3-4754-4E91-A58E-990AA878A7B6Q36937324-7DF50B66-2ABF-403E-854C-1C2D0EFE9652Q36990696-F983FA20-D20E-4D9B-AB64-2477211B3AA1Q37196855-D75B7FC7-7EC5-43B6-8FDA-EE19E3D9499DQ37241370-994D08F4-AA81-4FB1-BFF6-07A956287834
P2860
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Association of genetic variant ...... with outcome of HCV infection.
@ast
Association of genetic variant ...... with outcome of HCV infection.
@en
type
label
Association of genetic variant ...... with outcome of HCV infection.
@ast
Association of genetic variant ...... with outcome of HCV infection.
@en
prefLabel
Association of genetic variant ...... with outcome of HCV infection.
@ast
Association of genetic variant ...... with outcome of HCV infection.
@en
P2093
P1433
P1476
Association of genetic variant ...... with outcome of HCV infection.
@en
P2093
Angela J Frodsham
Branwen J W Hennig
Howard C Thomas
Jack Satsangi
Lyna Zhang
Mark Thursz
Mark Wright
Patricia Ramaley
Simon Hellier
Suzanne Knapp
P304
P356
10.1016/J.HEP.2003.09.027
P407
P577
2003-12-01T00:00:00Z